The value of a metabolic and immune-related gene signature and adjuvant therapeutic response in pancreatic cancer
BackgroundPancreatic ductal adenocarcinoma (PDAC) is a highly aggressive malignancy characterized by a dismal prognosis. Treatment outcomes exhibit substantial variability across patients, underscoring the urgent need for robust predictive models to effectively estimate survival probabilities and th...
Saved in:
Main Authors: | Danlei Ni, Jiayi Wu, Jingjing Pan, Yajing Liang, Zihui Xu, Zhiying Yan, Kequn Xu, Feifei Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2024.1475378/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improved Predictability of Diagnosis and Prognosis Using Serum‐ and Tissue‐Derived Extracellular Vesicles From Bulk mRNA Sequencing in Pancreatic Ductal Adenocarcinoma
by: Qian Zhu, et al.
Published: (2025-01-01) -
Adjuvant chemotherapy followed by concurrent chemoradiation is associated with improved survival for resected stage I‐II pancreatic cancer
by: Sung Jun Ma, et al.
Published: (2019-03-01) -
The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
by: Indah Kurnia Utami, et al.
Published: (2024-11-01) -
Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer
by: Xiaohong Liu, et al.
Published: (2025-01-01) -
DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma
by: Qianxue Wu, et al.
Published: (2025-01-01)